Endeavor

President Biden’s Diagnosis Spotlights Growing Progress in Prostate Cancer Care

CAR T-cell therapy, bisphosphonates and targeted radiation offer new hope for patients with advanced disease

Is Immunotherapy Before and After Surgery a Better Strategy for Certain Cancers?

Several studies from the ASCO Annual Meeting suggest earlier use of immunotherapy improves survival for colon, head and neck and stomach cancers

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

New Drug Duo Significantly Slows Progression of Aggressive Breast Cancer

Phase 3 trial shows sacituzumab govitecan and pembrolizumab outperform standard treatment in triple-negative breast cancer

Researchers Explore New Treatment for Aggressive Head and Neck Cancer

Early clinical trial results suggest dual drug therapy may improve survival for patients with HPV-negative head and neck cancer

New Oral Drug Shows Promise for Patients with HER2-Mutated Lung Cancer

Beamion LUNG-1 trial results highlight zongertinib’s strong tumor control and durable responses

Can Immunotherapy Spare Certain Patients From Surgery?

Dostarlimab offers organ preservation and better quality of life for patients with mismatch repair-deficient tumors

Experimental Drug Shows Promise for Patients With Rare Lung Cancer Mutation

New drug targets active form of KRAS, offering hope for lung cancer patients

Moffitt Study Uncovers a Way To Boost Treatment for Aggressive Melanoma

Combination treatment triggers immune response and limits tumor growth